69097-361Level 3
grisofulvin (grisofulvin)
**Product type:** Human Prescription Drug
**Active ingredient:** GRISEOFULVIN
**Strength:** 125 mg/5mL
**Dosage form:** Suspension
**Route:** Oral
**Labeler:** Cipla USA Inc.
**Marketing category:** ANDA (ANDA065354)
**Pharmacologic class:** Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
GET
/api/v1/systems/ndc_fda/nodes/69097-361Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.